Gregor Eisenwort

9PUBLICATIONS
46CO-AUTHORS
Gene and molecular therapyRegenerative medicine (incl. stem cells)Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 22, 2025
Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study.

Sonja Wurm, Jennifer M Moritz, Verena Petzer

|Mar 15, 2023
Engraftment in NSGSCF mice correlates with the WHO category and prognosis in systemic mastocytosis.

Michael Willmann, Barbara Peter, Katharina Slavnitsch

|Feb 23, 2023
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.

Daniel Ivanov, Jelena D Milosevic Feenstra, Irina Sadovnik

|Jul 09, 2022
CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells.

Mathias Schneeweiss-Gleixner, Yüksel Filik, Gabriele Stefanzl

|Jul 07, 2022
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph+ chronic myeloid leukemia.

Barbara Peter, Gregor Eisenwort, Irina Sadovnik

|Mar 31, 2021
Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemia.

Gregor Eisenwort, Irina Sadovnik, Alexandra Keller

Pageof 2

Frequent Collaborators

7 joint publications

Peter Valent

5 joint publications

Georg Greiner

4 joint publications

Thomas Rülicke

3 joint publications

Michael Willmann